Virtual Event | May 12, 2026

Distributed Manufacturing for CGT: Rent, Lease, or Buy in an Era of Overcapacity?

Source: Cell & Gene

In this Cell & Gene Live, Cell & Gene's Chief Editor, Erin Harris, was joined by Sugu Patro, Ph.D., SVP Global Process Development, at Kite Pharma and Emily Moran, Founder and Principal of 3LB Consulting. Together, they unpacked what biotech teams should prioritize when evaluating partners in an overcapacity market and how to align early manufacturing strategy with clinical and financial goals.

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)